Search

Repligen Corp

Geschlossen

BrancheGesundheitswesen

167.35 -1.29

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

166.41

Max

167.54

Schlüsselkennzahlen

By Trading Economics

Einkommen

-3.3M

5M

Verkäufe

9.9M

204M

KGV

Branchendurchschnitt

244.568

56.659

EPS

0.54

Gewinnspanne

2.453

Angestellte

2,000

EBITDA

-35M

-2.4M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+7.2% upside

Dividenden

By Acuity

Nächstes Ergebnis

27. Okt. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

2.8B

10B

Vorheriger Eröffnungskurs

168.64

Vorheriger Schlusskurs

167.35

Repligen Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

2. Sept. 2026, 19:26 UTC

Repligen Corp shares are higher during Wednesday's session, reaching a session high earlier today. The stock shows resilience amid broader market geopolitical tensions.

1. Sept. 2026, 20:01 UTC

Repligen Corp shares are lower today, continuing a decline from Monday's close amid rising oil prices and inflation concerns affecting market conditions.

31. Aug. 2026, 21:02 UTC

Repligen Corp shares are lower in after-market hours amid broader economic concerns and hawkish comments from Fed Chair Kevin Warsh on inflation and interest rates.

28. Aug. 2026, 23:01 UTC

Repligen Corp shares are higher in after-market hours, reflecting strong momentum and positioning near the upper end of their one-month trading range.

26. Aug. 2026, 19:46 UTC

News

Repligen Corp shares are lower during Wednesday's session amid broader market volatility and persistent inflationary pressures reflected in recent PCE data.

25. Aug. 2026, 22:01 UTC

Repligen Corp shares are lower in after-market trading, reflecting broader market caution ahead of key economic events and a drop in consumer confidence.

24. Aug. 2026, 19:36 UTC

Repligen Corp shares are higher today, continuing an upward trend since Friday. The stock showed volatility, peaking earlier in the session.

21. Aug. 2026, 22:31 UTC

Correlated Moves

Repligen Corp's after-market performance is roughly flat, reflecting a slight decline since Friday's close amid broader market weakness in the life sciences sector.

20. Aug. 2026, 19:51 UTC

Repligen Corp is gaining during Thursday's session, supported by strong movement in the Life Sciences Tools & Services sub-sector. Shares pulled back earlier but have advanced.

19. Aug. 2026, 20:02 UTC

Repligen Corp is advancing sharply, supported by gains in the Life Sciences Tools & Services sub-sector. The stock remains above its 20-day moving average.

18. Aug. 2026, 19:36 UTC

Repligen Corp shares are declining, continuing a downward trend since Monday. Broader market sentiment remains cautious amid rising treasury yields and inflation concerns.

14. Aug. 2026, 19:16 UTC

Repligen Corp shares are lower today amid a lack of specific news. Investor sentiment is cautious following a decline in U.S. retail sales.

13. Aug. 2026, 22:01 UTC

Repligen Corp shares are lower in after-market hours, dropping from a brief high. The price remains above its 20-day moving average.

12. Aug. 2026, 19:36 UTC

Repligen Corp shares are higher today amid broader market optimism following a modest increase in the core Consumer Price Index. No specific company news was identified.

11. Aug. 2026, 20:01 UTC

Repligen Corp shares are higher today, reflecting strong performance amid routine trading. The stock remains above its 20-day moving average.

10. Aug. 2026, 23:16 UTC

Repligen Corp shares are trading higher in after-market hours. The stock remains near the upper end of its one-month trading range.

7. Aug. 2026, 22:01 UTC

Repligen Corp shares are higher in after-market trading, continuing a trend of six consecutive sessions. Broader equity gains follow weaker employment data easing rate hike concerns.

6. Aug. 2026, 20:02 UTC

Repligen Corp shares are higher today, continuing gains from Wednesday. No specific company news was identified to explain the movement.

5. Aug. 2026, 20:02 UTC

Correlated Moves

Repligen Corp shares are higher today, bolstered by gains in Charles River Laboratories and positive sentiment in the life sciences sector.

4. Aug. 2026, 19:56 UTC

Repligen Corp shares are higher today, reflecting broader market strength amid a significant decline in crude oil prices. The stock is near its one-month range's upper end.

31. Juli 2026, 20:02 UTC

Repligen Corp shares are lower today amid broader market pressures and rising US Treasury yields. The stock reached a session low earlier.

30. Juli 2026, 21:02 UTC

Repligen Corp shares are higher in after-market trading, buoyed by positive investor sentiment amid a focus on corporate earnings and broader market trends.

29. Juli 2026, 16:12 UTC

Repligen Corp shares are lower Wednesday, breaking a trend of higher daily closes. Broader market conditions reflect rising crude oil prices and inflation concerns.

28. Juli 2026, 23:21 UTC

Repligen Corp shares are higher in after-market trading, reflecting strong momentum and trading near the upper end of its one-month range.

27. Juli 2026, 16:26 UTC

News

Repligen Corporation shares are lower as the company approaches its Q2 earnings report, with analysts projecting 10.7% revenue growth. Current price is $131.96.

24. Juli 2026, 19:06 UTC

News

Repligen Corp is under scrutiny as a stock to avoid, with concerns over its $763.3 million revenue and declining operating margins. Shares are trading lower today.

22. Juli 2026, 19:25 UTC

News
Event
Social Media

Repligen Corp is acquiring BioLife Solutions for about $1.5 billion, offering $11.25 in cash and stock, with a projected $20 million in synergies.

21. Juli 2026, 22:56 UTC

Repligen Corp shares are higher in after-market trading, despite a recent trend of lower closes. Broader market sentiment may be influenced by the Nikkei 225 surge.

20. Juli 2026, 18:06 UTC

Repligen Corp shares are higher today, reflecting positive market sentiment despite earlier intraday fluctuations. No specific news was identified to explain the movement.

Peer-Vergleich

Kursveränderung

Repligen Corp Prognose

Kursziel

By TipRanks

7.2% Vorteil

12-Monats-Prognose

Durchschnitt 179.67 USD  7.2%

Hoch 207 USD

Tief 145 USD

Basierend auf 11 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Repligen Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

11 ratings

10

Buy

1

Halten

0

Sell

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Repligen Corp

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
help-icon Live chat